Literature DB >> 21081745

Emphasizing the burden of proof: The American College of Cardiology 2008 Expert Panel Comments on the ENHANCE Trial.

Harlan M Krumholz1.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21081745     DOI: 10.1161/CIRCOUTCOMES.110.959577

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


× No keyword cloud information.
  6 in total

Review 1.  Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Authors:  Richard Kones; Umme Rumana
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

Review 2.  Human genetic insights into lipoproteins and risk of cardiometabolic disease.

Authors:  Nathan O Stitziel
Journal:  Curr Opin Lipidol       Date:  2017-04       Impact factor: 4.776

Review 3.  Leveraging human genetics to guide drug target discovery.

Authors:  Nathan O Stitziel; Sekar Kathiresan
Journal:  Trends Cardiovasc Med       Date:  2016-08-26       Impact factor: 6.677

4.  Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.

Authors:  Joseph S Ross; Sharon G Frazee; Susan B Garavaglia; Rebecca Levin; Haik Novshadian; Cynthia A Jackevicius; Glen Stettin; Harlan M Krumholz
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

5.  Inactivating mutations in NPC1L1 and protection from coronary heart disease.

Authors:  Nathan O Stitziel; Hong-Hee Won; Alanna C Morrison; Gina M Peloso; Ron Do; Leslie A Lange; Pierre Fontanillas; Namrata Gupta; Stefano Duga; Anuj Goel; Martin Farrall; Danish Saleheen; Paola Ferrario; Inke König; Rosanna Asselta; Piera A Merlini; Nicola Marziliano; Maria Francesca Notarangelo; Ursula Schick; Paul Auer; Themistocles L Assimes; Muredach Reilly; Robert Wilensky; Daniel J Rader; G Kees Hovingh; Thomas Meitinger; Thorsten Kessler; Adnan Kastrati; Karl-Ludwig Laugwitz; David Siscovick; Jerome I Rotter; Stanely L Hazen; Russell Tracy; Sharon Cresci; John Spertus; Rebecca Jackson; Stephen M Schwartz; Pradeep Natarajan; Jacy Crosby; Donna Muzny; Christie Ballantyne; Stephen S Rich; Christopher J O'Donnell; Goncalo Abecasis; Shamil Sunaev; Deborah A Nickerson; Julie E Buring; Paul M Ridker; Daniel I Chasman; Erin Austin; Iftikhar J Kullo; Peter E Weeke; Christian M Shaffer; Lisa A Bastarache; Joshua C Denny; Dan M Roden; Colin Palmer; Panos Deloukas; Dan-Yu Lin; Zheng-zheng Tang; Jeanette Erdmann; Heribert Schunkert; John Danesh; Jaume Marrugat; Roberto Elosua; Diego Ardissino; Ruth McPherson; Hugh Watkins; Alex P Reiner; James G Wilson; David Altshuler; Richard A Gibbs; Eric S Lander; Eric Boerwinkle; Stacey Gabriel; Sekar Kathiresan
Journal:  N Engl J Med       Date:  2014-11-12       Impact factor: 91.245

Review 6.  Overview of guidelines for the management of dyslipidemia: EU perspectives.

Authors:  Vicente Giner-Galvañ; María José Esteban-Giner; Vicente Pallarés-Carratalá
Journal:  Vasc Health Risk Manag       Date:  2016-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.